Asset Details
Do you wish to reserve the book?
FCER2 (CD23) Asthma-Related Single Nucleotide Polymorphisms Yields Increased IgE Binding and Egr-1 Expression in Human B Cells
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
FCER2 (CD23) Asthma-Related Single Nucleotide Polymorphisms Yields Increased IgE Binding and Egr-1 Expression in Human B Cells
Do you wish to request the book?
FCER2 (CD23) Asthma-Related Single Nucleotide Polymorphisms Yields Increased IgE Binding and Egr-1 Expression in Human B Cells
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
FCER2 (CD23) Asthma-Related Single Nucleotide Polymorphisms Yields Increased IgE Binding and Egr-1 Expression in Human B Cells
2014
Overview
CD23 is the low-affinity Fc receptor for IgE. When expressed on B cells, CD23 appears to play a role in regulation of IgE synthesis. Polymorphisms within FCER2, the gene encoding CD23, have been associated with atopy, increased risk of exacerbations in patients with asthma, and high serum IgE levels. A single-nucleotide polymorphism (rs2228137) present in exon 4 of FCER2 encodes a nonsynonymous amino acid change (R62W) and is the subject of the present analysis. Human B cell stable transfectants were established to characterize the functional relevance of the R62W SNP. We demonstrate that CD23b-R62W-expressing human B cells bind IgE with greater affinity than wild-type cells and display differences in kinetics of CD23-mediated ERK1/2 activation that may be responsible for the increased levels of Egr-1 mRNA observed after stimulation through CD23. Finally, the R62W SNP seems to alter the tertiary or quaternary structure of CD23 because in the absence of N-glycosylation the CD23b-R62W-expressing cells appear to be less sensitive to endogenous proteases. These observations may have implications in mechanisms responsible for the atopic phenotypes observed in patients with asthma who possess this genotype.
Publisher
American Thoracic Society
